The present invention includes isolated nucleic acids encoding fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). Also included are methods of using and producing the antibodies of the invention.

 
Web www.patentalert.com

< Autoimmune disease model animal

> Cosmetic emulsifiers

> Buprenorphine formulations for intranasal delivery

~ 00582